FDA Considers Restart of Trials with Fitusiran for Hemophilia A and B After Recent Setback
Officials of the U.S. Food and Drug Administration and Alnylam Pharmaceuticals have agreed on safety measures and a “risk mitigation…
Articles by Janet Stewart, MSc
European Medicines Agency Recommends Adynovi’s Approval for Hemophilia A
The European Medicines Agency has recommended marketing authorization for Shire’s Adynovi (BAX-855) as a treatment for adults and adolescents with hemophilia…
Eloctate Improves Joint Health in Hemophilia A, Phase 3 Study Shows
Interim results from the Phase 3 ASPIRE study indicate that patients with hemophilia A showed continuous improvement in joint health…
FDA Accepts Bayer Application for BAY94-9027 to Possibly Treat Hemophilia A
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s Biologics License Application (BLA) filing for BAY94-9027 to treat…
HIV Therapies May Also Prevent Genetic Mutations That Cause Hemophilia, Study Finds
Researchers at South Dakota State University (SDSU) studying mouse sperm found that drugs such as those used to treat HIV…